Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,029 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients.
Matthews DC, Kinney JW, Ritter A, Andrews RD, Toledano Strom EN, Lukic AS, Koenig LN, Revta C, Fillit HM, Zhong K, Tousi B, Leverenz JB, Feldman HH, Cummings J. Matthews DC, et al. Among authors: ritter a. Alzheimers Dement (N Y). 2024 Jul 9;10(3):e12490. doi: 10.1002/trc2.12490. eCollection 2024 Jul-Sep. Alzheimers Dement (N Y). 2024. PMID: 38988416 Free PMC article.
Alzheimer's disease drug development pipeline: 2017.
Cummings J, Lee G, Mortsdorf T, Ritter A, Zhong K. Cummings J, et al. Among authors: ritter a. Alzheimers Dement (N Y). 2017 May 24;3(3):367-384. doi: 10.1016/j.trci.2017.05.002. eCollection 2017 Sep. Alzheimers Dement (N Y). 2017. PMID: 29067343 Free PMC article. Review.
Alzheimer's disease drug development pipeline: 2018.
Cummings J, Lee G, Ritter A, Zhong K. Cummings J, et al. Among authors: ritter a. Alzheimers Dement (N Y). 2018 May 3;4:195-214. doi: 10.1016/j.trci.2018.03.009. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 29955663 Free PMC article.
Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience.
Miller JB, Cummings J, Nance C, Ritter A. Miller JB, et al. Among authors: ritter a. Alzheimers Dement (N Y). 2018 Jul 11;4:350-356. doi: 10.1016/j.trci.2018.06.006. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30175229 Free PMC article. Review.
Statistical advances in clinical trials and clinical research.
Shan G, Banks S, Miller JB, Ritter A, Bernick C, Lombardo J, Cummings JL. Shan G, et al. Among authors: ritter a. Alzheimers Dement (N Y). 2018 Jun 14;4:366-371. doi: 10.1016/j.trci.2018.04.006. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30175231 Free PMC article.
Alzheimer's disease drug development pipeline: 2019.
Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Cummings J, et al. Among authors: ritter a. Alzheimers Dement (N Y). 2019 Jul 9;5:272-293. doi: 10.1016/j.trci.2019.05.008. eCollection 2019. Alzheimers Dement (N Y). 2019. PMID: 31334330 Free PMC article.
Unique white matter structural connectivity in early-stage drug-naive Parkinson disease.
Mishra VR, Sreenivasan KR, Yang Z, Zhuang X, Cordes D, Mari Z, Litvan I, Fernandez HH, Eidelberg D, Ritter A, Cummings JL, Walsh RR. Mishra VR, et al. Among authors: ritter a. Neurology. 2020 Feb 25;94(8):e774-e784. doi: 10.1212/WNL.0000000000008867. Epub 2019 Dec 27. Neurology. 2020. PMID: 31882528 Free PMC article.
1,029 results